News and developments

Can Singapore learn from the European Health Data Space Act (“EHDSA”)? A discussion on the NEHR and the Proposed Health Information Bill (“SG HIB”)

 Introduction  The National Electronic Health Record (“NEHR”) system was set up with the goal of serving as a repository to collect different types of data of the patients’ summary health conditions and records based on their encounters with healthcare professions and clinicians throughout their life.
13 September 2024

Mergers and Acquisitions – David Getting Ready for the Takeover

Following our first article “Goliath taking over David”[1], we will now look at ways in which David should get itself ready for such a transaction.
05 September 2024

Mergers and Acquisitions – As Goliath takes over David – are the risks worth it?

Today’s mergers and acquisitions landscape involves more transactions between companies of difference in sizes (in terms of assets,
04 September 2024

Taking the driving seat on pharma and life science investments

Investments in the life science and pharmaceutical industries are a different ballgame.
25 July 2024

A Practical Checklist of Things to Avoid with New Launches of Prescription-Only Medicines in Singapore

Pharmaceutical companies that plan launches of prescription-only medicines need to be aware: there are regulatory matters in Singapore things which can interrupt your launch if they’re not sufficiently attended to.
08 July 2024

“Earned Media” – Legitimate Publicity for Medical Products or Disguised Product Promotion?

It should come as no surprise that the marketing of pharmaceutical products is regulated – and that even advertisements of such products are regulated.
04 July 2024
AI

The Thaler decision - AI Need Not Apply … At least Not yet….

The UK Supreme Court held, on 20 December 2023, that an AI system could NOT be an inventor for two UK Patent applications.
14 March 2024
Intellectual Property

Patentability Of Software In Singapore

13 June 2022